Table 2.
Patient | Susceptibility Testing Method | Minimum Inhibitory Concentrations 1 | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
FLU 2 | ITR 3 | ISA 4 | POS 5 | VRC 6 | CAS 7 | MFG 8 | AFG 9 | AmpB 10 | Flucy 11 | ||
1 | YestOne Sensititre | 128 | 0.12 | N/A | 0.06 | 0.5 | 0.12 | 0.12 | 0.12 | 1 | 8 |
2 | YestOne Sensititre | 256 | 0.25 | N/A | 0.12 | 2 | 0.12 | 0.12 | 0.12 | 2 | 0.12 |
3 | Broth Microdilution | ≥64 | 2 | 1 | 0.5 | 2 | N/A | N/A | 0.25 | N/A | N/A |
4 | Broth Microdilution | ≥64 | 0.25 | ≤0.016 | ≤0.016 | 0.25 | N/A | N/A | 0.125 | N/A | N/A |
5 | Broth Microdilution | ≥64 | 0.5 | 0.25 | ≤0.016 | 0.5 | N/A | N/A | 16 | N/A | N/A |
6 | Broth Microdilution | ≥64 | 0.25 | ≤0.016 | 0.06 | 2 | N/A | N/A | 0.5 | N/A | N/A |
7 | Broth Microdilution/E-Test | >256 | N/A | N/A | 0.5 | 2 | 2 | 4 | 4 | 2 | N/A |
8 | Broth Microdilution/E-Test | >256 | N/A | N/A | 0.25 | 2 | 16 | 4 | 4 | 2 | N/A |
9 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
10 | Broth Microdilution | 64 | 0.031 | <0.016 | <0.016 | 0.125 | N/A | 0.063 | 0.031 | 2 | N/A |
11 | YestOne Sensititre/Broth Microdilution | 2 | N/A | ≤0.03 | N/A | 0.015 | 0.06 | 0.12 | 0.12 | 1 | N/A |
2 | N/A | ≤0.03 | N/A | 0.06 | >8 | >8 | 4 |
1 N/A: information not available from source literature; 2 FLU: fluconazole; 3 ITR: itraconazole; 4 ISA: isavuconazole; 5 POS: posaconazole; 6 VRC: voriconazole; 7 CAS: caspofungin; 8 MFG: micafungin; 9 AFG: anidulafungin; 10 AmpB: amphotericin B; 11 Flucy: flucytosine.